when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Nephrology · news · pharmadog

← back to Nephrology

News · Nephrology

132 stories

Jul 13, 26STAT+: Pharmalittle: We’re reading about an RFK Jr. push against psychiatric meds, a Sanofi blood cancer drug, and morestat

Jul 10, 26STAT+: Pharmalittle: We’re reading about bigger drug discounts in Germany, drugmakers embracing secrecy, and morestat

Jul 10, 26Opinion: The primary care crisis paradoxstat

Jul 9, 26STAT+: Pharmalittle: We’re reading about FDA commissioner contenders, a heart drug failure, and morestat

Jul 9, 26STAT+: The quest to save Grace — and clear the way for rare disease patients everywherestat

Jul 8, 26STAT+: RFK Jr. plans to create list of injuries caused by Covid-19 vaccinesstat

Jul 8, 26Bryan Johnson’s chronic disease is notoriously difficult to diagnosestat

Jul 8, 26Transplants extended survival for patients whose stage 4 lung cancer hadn’t spread, study saysstat

Jul 8, 26STAT+: Europe will accelerate its review of RevMed’s drugstat

Jul 8, 26STAT+: Prime Medicine claims victory in dispute over gene-editing technology with Beam Therapeuticsstat

Jul 8, 26STAT+: Pharmalittle: We’re reading about a Vera kidney drug approval, a U.K. Enhertu pricing deal, and morestat

Jul 8, 26Another big premium hike on the horizonstat

Jul 8, 26Are glucose monitors a good thing for 2-year-olds? Experts look at risks, benefitsstat

Jul 7, 26STAT+: FDA approves Vera Therapeutics kidney disease treatmentstat

Jul 7, 26STAT+: Compass says depression drug has long-lasting benefitsstat

Jul 7, 26Vertex to acquire Crinetics in $10B foray into endocrine disease drugsbiopharma dive

Jul 7, 26STAT+: Pharmalittle: We’re reading about a $10 billion Vertex deal, the pace of FDA drug approvals, and morestat

Jul 7, 26Vera Therapeutics wins FDA nod for closely watched kidney disease drugbiopharma dive

Jul 2, 26Otsuka reports long-term kidney data key to Voyxact's bid for full approvalendpoints

Jul 1, 26Statins and blood pressure drugs changing health risks of obesity, study suggestsstat

Jul 1, 26BridgeBio gets funding for drug launch; United buys into cell therapybiopharma dive

Jul 1, 26Ipsen to buy Swiss biotech Memo Therapeutics in potential $800M dealbiopharma dive

Jul 1, 26STAT+: More signs that GLP-1s may help with peripheral artery diseasestat

Jul 1, 26Ipsen to scoop up Memo Therapeutics and its kidney infection drugendpoints

Jun 30, 26Unicycive gets second CRL for kidney drug as manufacturing woes continueendpoints

Jun 29, 2610 clinical trials to watch in the second half of 2026biopharma dive

Jun 18, 26Opinion: AI’s growing appetite for power is a public health issue. Here’s a fixstat

Jun 15, 26Covid vaccination cut risk of adverse heart events, large study findsstat

Jun 13, 26Opinion: ‘I’m pretty much all in’: An interview with a woman starting medical residency at almost 73stat

Jun 12, 26Merck brings Welireg-Keytruda combo to treat kidney cancerendpoints

← prevpage 3 of 5next →